oneplacenewsSource: ScienceDaily Health
Summary
Researchers have identified a molecule, SLAMF6, that weakens cancer-fighting T cells, hindering their effectiveness. By blocking this ‘brake’, researchers can enhance T cell responses against tumors in mice.
Why It Matters
This discovery reveals a critical mechanism behind cancer treatments failing, shedding light on potential new therapies that could enhance existing immuno-oncological approaches. By targeting SLAMF6, scientists may improve the durability and success of cancer treatments, ultimately leading to better patient outcomes.
